Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2014 | 2015 | 2016 | 2017 | 2018 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $28.2K | $288.1K | $191.1K | $514.3K | $1.5M | $2.2M | $457.0K |
| Cost of revenue | $0 | $0 | $38.2K | $73.7K | $162.8K | $643.4K | $1.1M | $213.0K |
| Gross profit | $0 | $28.2K | $249.9K | $117.4K | $351.5K | $879.8K | $1.1M | $244.0K |
| Gross margin | — | 100.0% | 86.7% | 61.4% | 68.3% | 57.8% | 50.8% | 53.4% |
| R&D | $56.7K | $230.1K | $308.1K | $302.4K | $160.7K | $85.7K | $64.3K | $68.0K |
| Operating income | −$489.0K | −$1.4M | −$1.5M | −$2.1M | −$1.5M | −$1.1M | −$1.4M | −$2.5M |
| EBITDA | −$853.8K | −$1.3M | −$1.5M | −$2.4M | −$1.8M | $6.0M | $6.5M | −$10.4M |
| Net income | −$810.7K | −$1.3M | −$1.3M | $1.9M | −$1.9M | $5.8M | $6.3M | $2.6M |
| Net margin | — | -4541.2% | -450.5% | 998.3% | -373.2% | 380.9% | 282.9% | 566.1% |
| EPS (diluted) | -0.03 | -0.02 | -0.02 | 0.02 | -0.02 | 0.06 | 0.07 | 0.03 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds OPBXF.
No tracked institution reports a position in OPBXF as of their last filing.
No one on the platform has traded OPBXF yet.
| $20M |
| — |
| KMSTFKadimastem Ltd | $3.21 | -3.02% | $10M | — |
| OCELOrganicell Regenerative Medicine, Inc. | $2.74 | -0.27% | $20M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.